Oral 250 bis 500 Mikrogramm pro Tag (Kapseln oder Tabletten, primr fr GI-Indikationen), subkutan 200 bis 500 Mikrogramm pro Tag in Bauch oder Oberschenkel (am wirksamsten fr Sehnen- und Muskelregeneration), topisch 1 bis 2 Milligramm lokal auf die Verletzung, Nasenspray 250 bis 500 Mikrogramm pro Tag bei geringerer Bioverfgbarkeit
A vial labeled eloralintide, cagrilintide, or petrelintide cannot be verified by appearance, powder color, cake size, or a non-specific purity certificate
Do I need a prescription for these peptides
Pre-Blend Dose Assessment (10 units / 0.10 mL daily) Component GHK-Cu Per-dose from Blend ~1.67 mg Typical Standalone 1-2 mg daily Assessment In range Component BPC-157 Per-dose from Blend ~0.33 mg Typical Standalone 0.25-0.5 mg daily Assessment In range Component TB-500 Per-dose from Blend ~0.33 mg Typical Standalone 2-5 mg per injection, 2x/week Assessment Below standalone injury range The 5:1:1 blend is convenience- and skin-focused
Year June 2026 Status Sermorelin still sits in FDA 503A Category 1 , meaning licensed compounding pharmacies can legally prepare it for patients with a valid prescription